Abstract |
The aim of this study was to examine the inhibitory effect of high molecular weight hyaluronan (HA) on nuclear factor ( NF)-kappaB activation by COOH-terminal heparin-binding fibronectin fragment (HBFN-f) in rheumatoid arthritis (RA) chondrocytes. When RA chondrocytes in monolayer or cartilage explants were cultured with HBFN-f, the fragment stimulated the phosphorylation and nuclear translocation of NF-kappaB, leading to nitric oxide (NO) production in association with inducible form of NO synthase (iNOS) up-regulation. Inhibition studies with NF-kappaB inhibitors indicated the requirement of NF-kappaB for HBFN-f-induced NO production. Pretreatment with 2700 kDa HA resulted in significant suppression of NF-kappaB activation by HBFN-f. HA also inhibited HBFN-f-stimulated NO production with down-regulation of iNOS. The present study clearly demonstrated that high molecular weight HA suppressed HBFN-f-activated NF-kappaB in RA chondrocytes. HA could down-regulate the catabolic action of fibronectin fragments like HBFN-f in RA joints as a potent NF-kappaB inhibitor.
|
Authors | Tadashi Yasuda, Takashi Nakamura |
Journal | Modern rheumatology
(Mod Rheumatol)
Vol. 17
Issue 5
Pg. 391-7
( 2007)
ISSN: 1439-7595 [Print] England |
PMID | 17929131
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Fibronectins
- NF-kappa B
- Nitric Oxide
- Hyaluronic Acid
- Heparin
- Chymotrypsin
- alpha-chymotrypsin
|
Topics |
- Arthritis, Rheumatoid
(drug therapy, metabolism)
- Cartilage
(metabolism)
- Cartilage, Articular
(metabolism)
- Cell Nucleus
(metabolism)
- Chondrocytes
(metabolism)
- Chymotrypsin
(pharmacology)
- Fibronectins
(chemistry, metabolism)
- Gene Expression Regulation
- Heparin
(chemistry)
- Humans
- Hyaluronic Acid
(metabolism, pharmacology)
- Models, Biological
- NF-kappa B
(metabolism)
- Nitric Oxide
(metabolism)
- Protein Binding
- Protein Structure, Tertiary
|